Adenocarcinoma Pancreatic Ductal clinical trials

Explore recruiting adenocarcinoma pancreatic ductal clinical trials.

Recruiting adenocarcinoma pancreatic ductal studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Adenocarcinoma Pancreatic Ductal trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Brightline-2: A Phase IIa/IIb, open-label, single-arm, multi-centre trial of BI 907828 for treatment of patients with locally advanced / metastatic, MDM2 amplified, TP53 wild-type biliary tract adenocarcinoma, pancreatic ductal adenocarcinoma, or other selected solid tumours

Spain, France, Belgium, Germany, Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

Adenocarcinoma Pancreatic Ductal trials by city

Adenocarcinoma Pancreatic Ductal in Toronto Adenocarcinoma Pancreatic Ductal in Vancouver Adenocarcinoma Pancreatic Ductal in Montreal Adenocarcinoma Pancreatic Ductal in Calgary Adenocarcinoma Pancreatic Ductal in Edmonton Adenocarcinoma Pancreatic Ductal in Ottawa Adenocarcinoma Pancreatic Ductal in Winnipeg Adenocarcinoma Pancreatic Ductal in Quebec City Adenocarcinoma Pancreatic Ductal in Hamilton Adenocarcinoma Pancreatic Ductal in Kitchener Adenocarcinoma Pancreatic Ductal in London Adenocarcinoma Pancreatic Ductal in Halifax Adenocarcinoma Pancreatic Ductal in New York Adenocarcinoma Pancreatic Ductal in Los Angeles Adenocarcinoma Pancreatic Ductal in Chicago Adenocarcinoma Pancreatic Ductal in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease